CSL Behring acquires
Biotech Company Calimmune ASX Announcement

28-August-2017 — CSL Limited to acquire US biotechnology company and its proprietary stem cell gene therapy platform. More.

CSL announces
Full-Year Results 2016-17 ASX announcement

16-August-2017 — CSL Limited announces 2016/17 Full Year Results for the period ending
30 June 2017. More.

Other recent news:

03-August- 2017  — CSL completes transaction to acquire a majority stake in Chinese plasma fractionator. More. 
10-July-2017 — CSL Limited has become aware that Bioverativ has filed complaints in the U.S. District Court for the District of Delaware and with the International Trade Commission. More.
23-June-2017 — CSL announced that the FDA has approved CSL Behring’s HAEGARDA®. More.

© 2017 CSL Limited